Regulation of amyloid precursor protein processing by serotonin signaling

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Pimenova, Anna A ^a,b   Thathiah, Amantha ^a,b   De Strooper, Bart ^a,b   Tesseur, Ina ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; AMYLOID PRECURSOR PROTEIN; BETA ARRESTIN; BETA SECRETASE; CASEIN KINASE II; CYCLIC AMP; GAMMA SECRETASE; GELATINASE B; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL TRISPHOSPHATE; PHOSPHOLIPASE C; SEROTONIN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL LINE; COGNITIVE DEFECT; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; SENILE PLAQUE; SIGNAL TRANSDUCTION; UPREGULATION;

ADENYLATE CYCLASE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ARRESTINS; CASEIN KINASE II; CELL LINE, TUMOR; CYCLIC AMP; GTP-BINDING PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; PHOSPHORIC MONOESTER HYDROLASES; PROTEOLYSIS; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TYPE C PHOSPHOLIPASES;

EID: 84907026866     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087014     Document Type: Article

References (85)

1. De Strooper B (2010) Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol Rev 90: 465-494.
2. Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, et al. (2004) A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 113: 1456-1464. (Pubitemid 39071701)
3. Donmez G, Wang D, Cohen DE, Guarente L (2010) SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 142: 320-332.
4. Bockaert J, Claeysen S, Compan V, Dumuis A (2008) 5-HT(4) receptors: history, molecular pharmacology and brain functions. Neuropharmacology 55: 922-931.
5. Spencer JP, Brown JT, Richardson JC, Medhurst AD, Sehmi SS, et al. (2004) Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease. Neuroscience 129: 49-54. (Pubitemid 39360940)
6. Matsumoto M, Togashi H, Mori K, Ueno K, Ohashi S, et al. (2001) Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies. J Pharmacol Exp Ther 296: 676-682. (Pubitemid 32187334)
7. Robert SJ, Zugaza JL, Fischmeister R, Gardier AM, Lezoualc'h F (2001) The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein. J Biol Chem 276: 44881-44888.
8. Cho S, Hu Y (2007) Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival. Exp Neurol 203: 274-278. (Pubitemid 44821167)
9. Tesseur I, Pimenova AA, Lo AC, Ciesielska M, Lichtenthaler SF, et al. (2013) Chronic 5-HT4 receptor activation decreases Abeta production and deposition in hAPP/PS1 mice. Neurobiol Aging 34: 1779-1789.
10. Cachard-Chastel M, Lezoualc'h F, Dewachter I, Delomenie C, Croes S, et al. (2007) 5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice. Br J Pharmacol 150: 883-892. (Pubitemid 46536635)
11. Shen F, Smith JA, Chang R, Bourdet DL, Tsuruda PR, et al. (2011) 5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment. Neuropharmacology 61: 69-79.
12. Micale V, Leggio GM, Mazzola C, Drago F (2006) Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia. Brain Res 1121: 207-215. (Pubitemid 44708901)
13. Consolo S, Arnaboldi S, Giorgi S, Russi G, Ladinsky H (1994) 5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. Neuroreport 5: 1230-1232.
14. Farlow MR, Cummings JL (2007) Effective pharmacologic management of Alzheimer's disease. Am J Med 120: 388-397. (Pubitemid 46627453)
15. Maillet M, Robert SJ, Cacquevel M, Gastineau M, Vivien D, et al. (2003) Crosstalk between Rap1 and Rac regulates secretion of sAPPalpha. Nat Cell Biol 5: 633-639. (Pubitemid 36818085)
16. Barthet G, Framery B, Gaven F, Pellissier L, Reiter E, et al. (2007) 5-hydroxytryptamine 4 receptor activation of the extracellular signal-regulated kinase pathway depends on Src activation but not on G protein or beta-arrestin signaling. Mol Biol Cell 18: 1979-1991. (Pubitemid 46911351)
17. Contesse V, Hamel C, Lefebvre H, Dumuis A, Vaudry H, et al. (1996) Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion. Mol Pharmacol 49: 481-493. (Pubitemid 26087816)
18. Ouadid H, Seguin J, Richard S, Chaptal PA, Nargeot J (1991) Properties and Modulation of Ca channels in adult human atrial cells. J Mol Cell Cardiol 23: 41-54.
19. Jorissen E, Prox J, Bernreuther C, Weber S, Schwanbeck R, et al. (2010) The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J Neurosci 30: 4833-4844.
20. Kuhn PH, Wang H, Dislich B, Colombo A, Zeitschel U, et al. (2010) ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J 29: 3020-3032.
21. Cochet M, Donneger R, Cassier E, Gaven F, Lichtenthaler SF, et al. (2013) 5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10. ACS Chem Neurosci 4: 130-140.
22. Le Gall SM, Bobe P, Reiss K, Horiuchi K, Niu XD, et al. (2009) ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Mol Biol Cell 20: 1785-1794.
23. Caccamo A, Oddo S, Billings LM, Green KN, Martinez-Coria H, et al. (2006) M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49: 671-682. (Pubitemid 43290127)
24. Jefferson T, Causevic M, auf dem Keller U, Schilling O, Isbert S, et al. (2011) Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo. J Biol Chem 286: 27741-27750.
25. Ahmad M, Takino T, Miyamori H, Yoshizaki T, Furukawa M, et al. (2006) Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases. J Biochem 139: 517-526. (Pubitemid 43667115)
26. Agholme L, Lindstrom T, Kagedal K, Marcusson J, Hallbeck M (2010) An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J Alzheimers Dis 20: 1069-1082.
27. Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, et al. (2002) The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet 11: 2615-2624. (Pubitemid 35174691)
28. Berlot CH (2002) A highly effective dominant negative alpha s construct containing mutations that affect distinct functions inhibits multiple Gs-coupled receptor signaling pathways. J Biol Chem 277: 21080-21085. (Pubitemid 34967419)
29. Lichtenthaler SF, Dominguez DI, Westmeyer GG, Reiss K, Haass C, et al. (2003) The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J Biol Chem 278: 48713-48719. (Pubitemid 41079512)
30. Reiter E, Lefkowitz RJ (2006) GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 17: 159-165.
31. Trzaskowski B, Latek D, Yuan S, Ghoshdastider U, Debinski A, et al. (2012) Action of molecular switches in GPCRs-theoretical and experimental studies. Curr Med Chem 19: 1090-1109.
32. Rovati GE, Capra V, Neubig RR (2007) The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state. Mol Pharmacol 71: 959-964. (Pubitemid 46456999)
33. Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J (1988) A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34: 880-887. (Pubitemid 19014410)
34. Chang WC, Ng JK, Nguyen T, Pellissier L, Claeysen S, et al. (2007) Modifying ligand-induced and constitutive signaling of the human 5-HT4 receptor. PLoS One 2: e1317.
35. Ponimaskin EG, Profirovic J, Vaiskunaite R, Richter DW, Voyno-Yasenetskaya TA (2002) 5-Hydroxytryptamine 4(a) receptor is coupled to the Galpha subunit of heterotrimeric G13 protein. J Biol Chem 277: 20812-20819. (Pubitemid 34967387)
36. Rhee SG (2001) Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70: 281-312.
37. Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361: 315-325.
38. Buxbaum JD, Ruefli AA, Parker CA, Cypess AM, Greengard P (1994) Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc Natl Acad Sci U S A 91: 4489-4493. (Pubitemid 24143459)
39. LeBlanc AC, Koutroumanis M, Goodyer CG (1998) Protein kinase C activation increases release of secreted amyloid precursor protein without decreasing Abeta production in human primary neuron cultures. J Neurosci 18: 2907-2913. (Pubitemid 28163220)
40. Shears SB (1998) The versatility of inositol phosphates as cellular signals. Biochim Biophys Acta 1436: 49-67.
41. Solyakov L, Cain K, Tracey BM, Jukes R, Riley AM, et al. (2004) Regulation of casein kinase-2 (CK2) activity by inositol phosphates. J Biol Chem 279: 43403-43410. (Pubitemid 39390639)
42. Gao Y, Wang HY (2007) Inositol pentakisphosphate mediates Wnt/beta-catenin signaling. J Biol Chem 282: 26490-26502. (Pubitemid 47443818)
43. Vingtdeux V, Marambaud P (2012) Identification and biology of alpha-secretase. J Neurochem 120 Suppl 1: 34-45.
44. Thathiah A, Horre K, Snellinx A, Vandewyer E, Huang Y, et al. (2013) beta-arrestin 2 regulates Abeta generation and gamma-secretase activity in Alzheimer's disease. Nat Med 19: 43-49.
45. Liu X, Zhao X, Zeng X, Bossers K, Swaab DF, et al. (2013) beta-arrestin1 regulates gamma-secretase complex assembly and modulates amyloid-beta pathology. Cell Res 23: 351-365.
46. Bandyopadhyay S, Goldstein LE, Lahiri DK, Rogers JT (2007) Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease. Curr Med Chem 14: 2848-2864. (Pubitemid 350201652)
47. Robert S, Maillet M, Morel E, Launay JM, Fischmeister R, et al. (2005) Regulation of the amyloid precursor protein ectodomain shedding by the 5-HT4 receptor and Epac. FEBS Lett 579: 1136-1142. (Pubitemid 40248678)
48. Smrcka AV, Sternweis PC (1993) Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C beta by G protein alpha and beta gamma subunits. J Biol Chem 268: 9667-9674. (Pubitemid 23146026)
49. Kozasa T, Hepler JR, Smrcka AV, Simon MI, Rhee SG, et al. (1993) Purification and characterization of recombinant G16 alpha from Sf9 cells: activation of purified phospholipase C isozymes by G-protein alpha subunits. Proc Natl Acad Sci U S A 90: 9176-9180. (Pubitemid 23306475)
50. Lezoualc'h F, Robert SJ (2003) The serotonin 5-HT4 receptor and the amyloid precursor protein processing. Exp Gerontol 38: 159-166. (Pubitemid 36110509)
51. Marambaud P, Ancolio K, Alves da Costa C, Checler F (1999) Effect of protein kinase A inhibitors on the production of Abeta40 and Abeta42 by human cells expressing normal and Alzheimer's disease-linked mutated betaAPP and presenilin 1. Br J Pharmacol 126: 1186-1190. (Pubitemid 29123754)
52. Lee RK, Wurtman RJ, Cox AJ, Nitsch RM (1995) Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc Natl Acad Sci U S A 92: 8083-8087.
53. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258: 304-307.
54. Nitsch RM, Deng M, Growdon JH, Wurtman RJ (1996) Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J Biol Chem 271: 4188-4194. (Pubitemid 26070520)
55. Lumbreras M, Baamonde C, Martinez-Cue C, Lubec G, Cairns N, et al. (2006) Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease. Amino Acids 31: 449-456. (Pubitemid 44853466)
56. Jolles J, Bothmer J, Markerink M, Ravid R (1992) Phosphatidylinositol kinase is reduced in Alzheimer's disease. J Neurochem 58: 2326-2329.
57. Albasanz JL, Dalfo E, Ferrer I, Martin M (2005) Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes. Neurobiol Dis 20: 685-693. (Pubitemid 41619345)
58. Lenzken SC, Stanga S, Lanni C, De Leonardis F, Govoni S, et al. (2010) Recruitment of casein kinase 2 is involved in AbetaPP processing following cholinergic stimulation. J Alzheimers Dis 20: 1133-1141.
59. Hashimoto G, Sakurai M, Teich AF, Saeed F, Aziz F, et al. (2012) 5-HT(4) receptor stimulation leads to soluble AbetaPPalpha production through MMP-9 upregulation. J Alzheimers Dis 32: 437-445.
60. Jacobsen KT, Adlerz L, Multhaup G, Iverfeldt K (2010) Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases. J Biol Chem 285: 10223-10231.
61. Camden JM, Schrader AM, Camden RE, Gonzalez FA, Erb L, et al. (2005) P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing. J Biol Chem 280: 18696-18702. (Pubitemid 41379570)
62. Delarasse C, Auger R, Gonnord P, Fontaine B, Kanellopoulos JM (2010) The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein. J Biol Chem 286: 2596-2606.
63. Ansanay H, Sebben M, Bockaert J, Dumuis A (1996) Pharmacological comparison between [3H]GR 113808 binding sites and functional 5-HT4 receptors in neurons. Eur J Pharmacol 298: 165-174.
64. Van den Wyngaert I, Gommeren W, Verhasselt P, Jurzak M, Leysen J, et al. (1997) Cloning and expression of a human serotonin 5-HT4 receptor cDNA. J Neurochem 69: 1810-1819. (Pubitemid 27452725)
65. Milligan G, Unson CG, Wakelam MJ (1989) Cholera toxin treatment produces down-regulation of the alpha-subunit of the stimulatory guanine-nucleotide- binding protein (Gs). Biochem J 262: 643-649. (Pubitemid 19228148)
66. Shen KF, Crain SM (1990) Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions. Brain Res 531: 1-7.
67. Hohenegger M, Waldhoer M, Beindl W, Boing B, Kreimeyer A, et al. (1998) Gsalpha-selective G protein antagonists. Proc Natl Acad Sci U S A 95: 346-351.
68. Lehmann DM, Seneviratne AM, Smrcka AV (2008) Small molecule disruption of G protein beta gamma subunit signaling inhibits neutrophil chemotaxis and inflammation. Mol Pharmacol 73: 410-418. (Pubitemid 351159211)
69. Harris DN, Asaad MM, Phillips MB, Goldenberg HJ, Antonaccio MJ (1979) Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives. J Cyclic Nucleotide Res 5: 125-134. (Pubitemid 9185897)
70. Gao Y, Usha Raj J (2002) Effects of SQ 22536, an adenylyl cyclase inhibitor, on isoproterenol-induced cyclic AMP elevation and relaxation in newborn ovine pulmonary veins. Eur J Pharmacol 436: 227-233. (Pubitemid 34164702)
71. Onoda JM, Braun T, Wrenn SM Jr (1987) Characterization of the purine-reactive site of the rat testis cytosolic adenylate cyclase. Biochem Pharmacol 36: 1907-1912. (Pubitemid 17100210)
72. Legrand AB, Narayanan TK, Ryan US, Aronstam RS, Catravas JD (1990) Effects of adenosine and analogs on adenylate cyclase activity in cultured bovine aortic endothelial cells. Biochem Pharmacol 40: 1103-1109. (Pubitemid 20259717)
73. Coluccia AM, Benati D, Dekhil H, De Filippo A, Lan C, et al. (2006) SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60 (c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling. Cancer Res 66: 2279-2286.
74. Vultur A, Buettner R, Kowolik C, Liang W, Smith D, et al. (2008) SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. Mol Cancer Ther 7: 1185-1194.
75. Amtmann E (1996) The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C. Drugs Exp Clin Res 22: 287-294.
76. Tschaikowsky K, Meisner M, Schonhuber F, Rugheimer E (1994) Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-ylxanthogenate (D609). Br J Pharmacol 113: 664-668. (Pubitemid 24326797)
77. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, et al. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268: 9194-9197. (Pubitemid 23145960)
78. Jacobson PB, Kuchera SL, Metz A, Schachtele C, Imre K, et al. (1995) Anti-inflammatory properties of Go 6850: a selective inhibitor of protein kinase C. J Pharmacol Exp Ther 275: 995-1002. (Pubitemid 26027054)
79. Chang YT, Choi G, Bae YS, Burdett M, Moon HS, et al. (2002) Purine-based inhibitors of inositol-1,4,5-trisphosphate-3-kinase. Chembiochem 3: 897-901. (Pubitemid 36002307)
80. Mayr GW, Windhorst S, Hillemeier K (2005) Antiproliferative plant and synthetic polyphenolics are specific inhibitors of vertebrate inositol-1,4, 5-trisphosphate 3-kinases and inositol polyphosphate multikinase. J Biol Chem 280: 13229-13240. (Pubitemid 40517206)
81. Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, et al. (2001) Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2'). FEBS Lett 496: 44-48. (Pubitemid 32436419)
82. Pagano MA, Andrzejewska M, Ruzzene M, Sarno S, Cesaro L, et al. (2004) Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetra- bromobenzimidazole. J Med Chem 47: 6239-6247. (Pubitemid 39587248)
83. Zien P, Duncan JS, Skierski J, Bretner M, Litchfield DW, et al. (2005) Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2. Biochim Biophys Acta 1754: 271-280. (Pubitemid 41797708)
84. Galardy RE, Cassabonne ME, Giese C, Gilbert JH, Lapierre F, et al. (1994) Low molecular weight inhibitors in corneal ulceration. Ann N Y Acad Sci 732: 315-323.
85. Moss ML, Rasmussen FH (2007) Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening. Anal Biochem 366: 144-148. (Pubitemid 46898217)